Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Surgical Management for Cognitive Deficit in Chronic Rhinosinusitis
NCT04291118Unknown
- Sponsor
- St. Paul's Hospital
- Start
- Feb 2020
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of EPI-EE in chronic rhinosinusitis (CRS), sponsored by St. Paul's Hospital. Primary endpoint: Modified mini mental state examination at 24 weeks. Status: unknown.
02
Drugs
EPI-EE
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT04291118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291118.